Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Stocks

Missed the Gilead Surge? Here’s What You Need to Know About the Big Move

by July 25, 2024
July 25, 2024
Missed the Gilead Surge? Here’s What You Need to Know About the Big Move

In late June, Gilead Sciences (GILD) stock surged following positive results of a late-stage trial for its latest HIV drug. 

The big market buzz was that Gilead was on the verge of something huge, and investors were not about to wait around for proof. They dove in early, seeing the price jump as a prime “ground floor” opportunity.

Expecting a pullback, given the speculative nature of the spike, there were key levels where a bounce could occur, providing an opportunity for you to ride Gilead’s momentum, even if just for a swing trade. The bullish thesis worked out, so let’s examine what happened.

What Happened and Where’s GILD Going?

The Gilead chart below zooms in on the price action following the trial results. The big unknown at the time was whether the spike on June 20 was going to pull back, and whether a pullback would end the uptrend. 

CHART 1. DAILY CHART OF GILEAD SCIENCES. The stock price pulled back, and the levels projected in June have so far held. Chart source: StockCharts.com. For educational purposes.

Before the Pullback in the Stock Price

What made this decision point particularly difficult were the following:

A StockCharts Technical Rank (SCTR) score of 30 (see blue arrow) wasn’t by any means promising, but from a bullish perspective, it also meant the potential for a ground-floor entry.The Chaikin Money Flow (CMF)  indicated that buying pressure was fading (see blue dotted line in the CMF indicator window), suggesting a pullback or resumption of the downtrend.

With strong bullish sentiment hinging on an upcoming FDA trial and shaky technicals aside from a solid breakout, a long trade might have felt like a coin toss, one slightly favoring the bulls. Hence, the importance of the key levels $68 and $66 and the 50-day simple moving average (SMA).

After the Pullback in the Stock Price

Let’s zoom in to the same chart above.

CHART 2. DAILY CHART OF GILEAD SCIENCES. Here, you can see the exact entry points and how prices respected the levels. Chart source: StockCharts.com. For educational purposes.

Here, you can see that the $66 support level converged with the 50-day SMA. GILD respected this level as buyers jumped in, anticipating a bounce, which they did get. Although the CMF entered negative territory, you can see how selling pressure began to fizzle out, and buying pressure overtook the bears.

As prices took out the June high, its pullback respected the $70.50 level (see second magenta circle), launching GILD to take out critical resistance right below $75 (see heavy blue dotted line).

The question is whether, upon a third pullback, the stock price will respect support at $75 and surge to (or beyond) $79. 

At the Close

You might be wondering if GILD is still a buy. It was a buy (emphasis on “was”), as the price action presented an ideal opportunity on the ground level. If you’re a longer-term investor, it would be wise to wait and see how GILD fares in light of its final testing period and FDA review process. 

If anything, the June GILD scenario underscores the importance of acting on key levels when the market flashes a fleeting opportunity amidst drastic (and bullish) fundamental and technical shifts. 

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

0
FacebookTwitterGoogle +Pinterest
previous post
Q&A with Dr. Jaime Klimsey Pickett DVM: A Visionary in Veterinary Medicine
next post
Kamala Harris vetting list of possible running mates with 4 standouts: report

You may also like

UPSidedown Earnings Sink Stocks

April 26, 2023

BULLISH on These Options Trade Ideas

February 3, 2025

Will This Massive Reverse Head & Shoulders Bottom...

April 16, 2023

Weekend Daily: The Perfect Storm – U.S. Dollar,...

October 22, 2022

Small Caps are Set to Skyrocket in 2025—Here’s...

December 11, 2024

Down, Then Up, Up and Away!

September 9, 2022

Week Ahead: NIFTY Set To Consolidate In A...

February 11, 2024

Silver Cross Index Tops Beneath Signal Line on...

March 29, 2025

Is the Stock Market Overvalued? Here’s How To...

June 30, 2023

Powerful 2-Timeframe Setup

June 30, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Warren, Trump, and the Debt Limit

      June 25, 2025
    • Russian official says Moscow has ‘no intention’ of supplying Iran with warheads, following Trump taunts

      June 25, 2025
    • Top DOJ official faces test in Senate over nomination to become federal judge

      June 25, 2025
    • Tube to be powered by clean solar energy under new TfL and EDF Renewables deal

      June 25, 2025
    • Co-op to halt sales of Israeli goods and other imports from ‘countries of concern’

      June 25, 2025
    • HMRC targets high earners in record tax crackdown after £1.5bn haul

      June 25, 2025

    Categories

    • Business (8,305)
    • Investing (2,070)
    • Politics (15,790)
    • Stocks (3,167)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved